โข
VT
VTGN
Vistagen Therapeutics, Inc. Common Stock
polygonPHARMACEUTICAL PREPARATIONS
--
Price Chart
Market Cap
25.05M
Volume
42.61K
52W High
$5.14
52W Low
$0.62
Open
$0.64
Prev Close
$0.63
Day Range
0.64 - 0.64
About Vistagen Therapeutics, Inc. Common Stock
Vistagen Therapeutics Inc is a biotechnology firm. The company isย neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.
Latest News
Phoenix Education Partners, Inc. Announcement: If You Have Suffered Losses in Phoenix Education Partners, Inc., You Are Encouraged to Contact The Rosen Law Firm About Your Rights
GlobeNewswire Inc.โขYesterday
ืจืืื, ืืฉืจื ืขืืจืื ืืื ืืืืื ืืืืืืืช ืืฉืงืืขืื, ืืขืืื ืืช ืืฉืงืืขื Vistagen Therapeutics, Inc ืืงืื ืืืขืืฅ ืืฉืคืื ืืคื ื ืืืืขื ืืืืจืื ืืืฉืื ืืชืืืขื ืืืฆืืืืช ืื ืืืจืืช ืขืจื - VTGN
GlobeNewswire Inc.โขJan 17
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTGN
GlobeNewswire Inc.โขJan 17
Portnoy Law Firm Announces Class Action on Behalf of Vistagen Therapeutics, Inc. Investors
GlobeNewswire Inc.โขJan 16
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Vistagen Therapeutics
GlobeNewswire Inc.โขJan 16
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Vistagen Therapeutics, Inc. (VTGN)
GlobeNewswire Inc.โขJan 16
All You Need to Know About VistaGen Therapeutics Rating Upgrade to Buy
BenzingaโขSep 6
Does VistaGen Therapeutics, Inc. (VTGN) Have the Potential to Rally 160% as Wall Street Analysts Expect?
Zacks Investment ResearchโขFeb 21